Talkiatry has raised $210 million in a Series D funding round led by Perceptive Advisors, bringing its total funding to over $400 million to enhance its online psychiatry platform and expand its capabilities in providing mental health care across the United States.
Information on the target
Talkiatry, an online psychiatry platform, has successfully raised $210 million in a Series D funding round, bringing its total funding to over $400 million. The investment was led by Perceptive Advisors, with participation from notable investors including Andreessen Horowitz, blisce/, Left Lane Capital, and Sofina. Additionally, the funding round included a loan agreement from Banc of California. Talkiatry is recognized as the largest private employer of psychiatrists in the United States, employing over 800 specialists and providing more than 3 million consultations to date.
The platform partners with over 100 insurance providers, covering more than 170 million individuals across the nation. Talkiatry has established collaborations with over 50 healthcare institutions, including one-third of the top 20 hospitals in the U.S., through its 'Mindshare Partner Program' launched at the end of 2023. The company addresses various mental health conditions, including anxiety, depression, bipolar disorder, obsessive-compulsive disorder, and post-traumatic stress disorder, by matching patients with psychiatrists through online assessments and offering video consultations with prescription services when necessary.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry overview in the target’s specific country
The mental health industry in the United States has experienced significant growth, particularly in the wake of the COVID-19 pandemic, which has heightened awareness and demand for mental health services. The increasing prevalence of mental health disorders, coupled with a growing a
Similar Deals
Gannet BioChem → Laysan Bio
2026
CenterWell Senior Primary Care → MaxHealth
2026
Berkadia → Three Skilled Nursing Facilities
2026
Perceptive Advisors
invested in
Talkiatry
in 2023
in a Other deal
Disclosed details
Transaction Size: $210M